Catalent Inc
(NYSE:CTLT)
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
top performing CTLT trades
![Daniel Goldman headshot](https://clerk.house.gov/content/assets/img/members/G000599.jpg)
Daniel Goldman
House (D-NY)
28.60%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Catalent trades made by congress members.
![]() Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Purchase | Apr 17, 2023 | Mar 07, 2023 | House |
![]() Susie LeeHouse (D-NV) | $1K - $15K | stock | Sale | Dec 29, 2022 | Nov 30, 2022 | House |